Sonnest, Inc.
Sonnest, Inc. is a pre-clinical stage diagnostic and therapeutic imaging company developing Electrast™, a voltage-sensitive ultrasound imaging agent that will allow clinicians to assess and monitor the perfusion of the heart at the bedside, in real-time using traditional ultrasound techniques.
![Three Sonnest team members discuss in Pennovation space](/sites/default/files/styles/wide/public/images/sonnest.png?itok=x-ypr8P8)